Spots Global Cancer Trial Database for Oropharynx (OPX) Biomarker Trial
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Oropharynx (OPX) Biomarker Trial
Official Title: Oropharynx (OPX) Biomarker Trial
Study ID: NCT06356272
Conditions
Interventions
Study Description
Brief Summary: The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.
Detailed Description: PRIMARY OBJECTIVE: I. To identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not present when disease is absent (i.e., after treatment, in HPV negative patients or in normal controls). OUTLINE: This is an observational study. Patients undergo blood sample collection, saliva sample collection, complete questionnaires and have their medical records reviewed on study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact Details
Name: Kathryn M. Van Abel, M.D.
Affiliation: Mayo Clinic in Rochester
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
